Sukeshi Arora MD
@DrSukeshiArora
Followers
946
Following
13K
Media
357
Statuses
4K
Yogi, medical oncologist caring for patients with GI cancers, she/her. Views are my own. Have a blessed day! @UTHealthSAMDA #GIcancers insta: @yogaoncology
San Antonio, TX
Joined August 2019
RT @mayscancer: This conference provides a comprehensive update on the multidisciplinary management of pancreatic cancer, focusing on the c….
0
1
0
RT @mayscancer: The San Antonio Liver Cancer Symposium is pleased to extend a third-day conference on Saturday, October 11, focusing on Pan….
mayscc.eventsair.com
0
3
0
RT @mayscancer: Don’t miss the opportunity to attend the 2025 San Antonio Liver Cancer Symposium!. Check out Dr. Cervantez’s session on Sur….
0
1
0
RT @SaludAmerica: SPEAKER ANNOUNCEMENT!📣. Register today for the 2026 ASCL Conference in San Antonio, Texas and hear from @DrSukeshiArora.….
0
5
0
RT @mayscancer: ABSTRACT SUBMISSIONS DUE AUG. 1! Share your groundbreaking research on liver cancer epidemiology, survivorship, and prevent….
0
1
0
RT @JGeriOnc: Oncologist perspectives on the acceptability, appropriateness, and feasibility of the Cancer and Aging Research Group (CARG)….
geriatriconcology.net
The clinical uptake of validated chemotherapy toxicity predictor tools for older adults with cancer remains low. In this qualitative study, we sought to evaluate oncologist perspectives on the...
0
8
0
RT @GillSharlene: 📛bolus!.👇another reminder that omitting the 5FU bolus in 5FU-based metastatic #GIcancer protocols is the right thing to d….
0
10
0
RT @AACR: Since a 2018 liver transplant for her inoperable cancer, Lorrinda Gray-Davis has devoted herself to organ transplant advocacy and….
0
1
0
Join us for the 5th annual SA Liver Cancer Symposium Oct 9-10 in SA! Abstracts due Aug 1! Submit anything liver-related, top 3 will be chosen for oral presentation @mayscancer @UTHealthSA @uhstransplant @SABCSSanAntonio.
ABSTRACT SUBMISSIONS DUE AUG. 1! Share your groundbreaking research on liver cancer epidemiology, survivorship, and prevention at the San Antonio Liver Cancer Symposium. Submit your abstract today. We look forward to seeing you on October 9-11!
0
4
9
Thank you for the invitation to speak at #ASCl @SaludAmerica @UTHealthSA! Looking forward to this outstanding and unique conference.
SPEAKER ANNOUNCEMENT!📣. Register today for the 2026 ASCL Conference in San Antonio, Texas and hear from @DrSukeshiArora. Find more information at . #ASCL206 #LatinoCancer2026
0
2
9
RT @HoustonPubMedia: As the death toll rises after the Central Texas floods, Rep. Joaquin Castro, D-Texas, says officials owe a thorough in….
houstonpublicmedia.org
Rep. Joaquin Castro, D-Texas, says affected Texans are owed an investigation into what went wrong with evacuating flooded areas and how it can be prevented from happening again.
0
6
0
RT @Erman_Akkus: Revolution Medicines Announces FDA Breakthrough Therapy Designation for Daraxonrasib in Previously Treated Metastatic Panc….
ir.revmed.com
Breakthrough Therapy Designation based on promising early clinical evidence observed with daraxonrasib in patients with pancreatic ductal adenocarcinoma (PDAC) RASolute 302, a Phase 3 registrational...
0
19
0
Missed @ASCO this year but proud to haw our fellow presenting our #HCC molecular data with @caris and @mayscancer. Our cancer center director @LeiZheng197721 showing the support!
1
0
5
RT @NiuSanford: PANOVA-3: gem/abraxane +/- TTF in locally advanced pancreas cancer. #ASCO25. As compared to other approved LAPC therapies,….
0
22
0
RT @jordanberlin5: Who else thinks that journals (who make profits off of our work) should be paying for reviews?.
0
4
0
RT @YoungSIOG: 📢 Calling all Young SIOGers!.We’re launching a new article series in the Journal of Geriatric Oncology.What oncologists need….
0
9
0
RT @diegoadiazg: 🧬 Organ preservation in early-stage dMMR tumors?. Neoadjuvant PD-1 blockade with dostarlimab led to clinical complete resp….
0
24
0